We have analyzed FDA-approved macrocyclic drugs, clinical candidates, and the recent literature to understand how macrocycles are used in drug discovery. Current drugs are …
DG Jimenez, V Poongavanam… - Journal of Medicinal …, 2023 - ncbi.nlm.nih.gov
We have analyzed FDA-approved macrocyclic drugs, clinical candidates, and the recent literature to understand how macrocycles are used in drug discovery. Current drugs are …
DG Jiménez, V Poongavanam… - Journal of Medicinal …, 2023 - diva-portal.org
We have analyzed FDA-approved macrocyclic drugs, clinical candidates, and the recent literature to understand how macrocycles are used in drug discovery. Current drugs are …
DG Jimenez, V Poongavanam… - Journal of medicinal …, 2023 - pubmed.ncbi.nlm.nih.gov
We have analyzed FDA-approved macrocyclic drugs, clinical candidates, and the recent literature to understand how macrocycles are used in drug discovery. Current drugs are …
V Poongavanam, J Kihlberg - Journal of Medicinal Chemistry, 2023 - europepmc.org
We have analyzed FDA-approved macrocyclic drugs, clinical candidates, and the recent literature to understand how macrocycles are used in drug discovery. Current drugs are …
V Poongavanam, J Kihlberg - Journal of Medicinal Chemistry, 2023 - europepmc.org
We have analyzed FDA-approved macrocyclic drugs, clinical candidates, and the recent literature to understand how macrocycles are used in drug discovery. Current drugs are …